(Q35852568)

10 August 2017

Partial nephrectomy in the setting of metastatic renal cell carcinoma (English)

1 reference

10 August 2017

Kara N Babaian

1

1 reference

10 August 2017

Megan M Merrill

2

1 reference

10 August 2017

Surena Matin

3

1 reference

10 August 2017

Pheroze Tamboli

4

1 reference

10 August 2017

Nizar M Tannir

5

1 reference

10 August 2017

Eric Jonasch

6

1 reference

10 August 2017

Christopher G Wood

7

1 reference

10 August 2017

Jose A Karam

8

1 reference

10 August 2017

language of work or name

English

0 references

publication date

8 February 2014

1 reference

10 August 2017

1 reference

10 August 2017

192

1 reference

10 August 2017

1

1 reference

10 August 2017

36-42

1 reference

Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

Is patient outcome compromised during the initial experience with robot-assisted radical cystectomy? Results of 164 consecutive cases

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

Metastatic potential of a renal mass according to original tumour size at presentation.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4502598

Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma

24 September 2018

1 reference

12 December 2020

The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses

1 reference

12 December 2020

Cytoreductive Partial Nephrectomy Does Not Undermine Cancer Control in Metastatic Renal Cell Carcinoma: A Population-Based Study

1 reference

12 December 2020

Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy

1 reference

12 December 2020

Nephron sparing surgery in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma

1 reference

12 December 2020

Metachronous Bilateral Renal Cell Carcinoma: Risk Assessment, Prognosis and Relevance of the Primary-Free Interval

1 reference

12 December 2020

10.1016/J.JURO.2014.01.086

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference